ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of May

May 31, 2013

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

September 3, 2010

In Brief: NIDR, NCI award $2.8 Million In Grants For Oral Cancer research Centers

October 4, 1996

AACI, SCO, ACCC Hold Meeting With HCFA On DRG Issue

June 17, 1983

An Earmark For Pancreatic Cancer

August 3, 2012

Women’s Caucus Calls For Wide Mammogram Payment

March 18, 1994